438
Views
22
CrossRef citations to date
0
Altmetric
REVIEW

Quality of Life: The Ultimate Outcome Measure of Interventions in Major Depressive Disorder

, MD, FAPA , MD, , MD, , MD, , MD, , MD, MPH, MBA, , MD, , MD & , MD show all
Pages 229-239 | Received 02 Jul 2010, Accepted 27 Mar 2011, Published online: 15 Sep 2011

REFERENCES

  • Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997;349:1498–504.
  • World Health Organization. Mental health and substance abuse. Facts and figures. Conquering depression. 2006. At http://www.searo.who.int/en/Section1174/Section1199/Section 1567/Section1826.htm
  • Commonwealth Department of Health and Aged Care; Australian Institute of Health and Welfare. National health priority areas report: mental health 1998. Canberra, Australia, 1999. http://aihw.gov.au/publication-detail/?id = 6442467062
  • Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005;62:617–27.
  • Zung WW, Broadhead WE, Roth ME. Prevalence of depressive symptoms in primary care. J Fam Pract 1993;37:337–44.
  • Whooley MA, de Jonge P, Vittinghoff E, Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008;300:2379–88.
  • Carney RM, Blumenthal JA, Freedland KE, Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005;165:1486–91.
  • Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005;38:432–8.
  • Pence BW. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother 2009;63:636–40.
  • Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 2008;70:539–45.
  • Regan KL. Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review. J Cardiovasc Nurs 2008;23:489–96.
  • Horberg MA, Silverberg MJ, Hurley LB, Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr 2008;47:384–90.
  • Walkup J, Wei W, Sambamoorthi U, Crystal S. Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q 2008;79:43–53.
  • World Health Organization. Preamble to the Constitution of the World Health Organization. 1948. http://www.who.int/governance/eb/who_constitution_en.pdf
  • Trivedi MH, Daly EJ. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend 2007;88(suppl 2):S61–71.
  • Greer TL, Kurian BT, Trivedi MH. Defining and measuring functional recovery from depression. CNS Drugs 2010;24:267–84.
  • World Health Organization Quality of Life Group. Measuring quality of life. 1997. http://www.who.int/mental_health/media/68.pdf
  • IsHak WW, Burt T, Sederer LI, eds. Outcome measurement in psychiatry: a critical review. Washington, DC: American Psychiatric Publishing, 2002.
  • IsHak WW. Outcome assessment in depression. Psychiatr Times 2008;25:10–2.
  • Gershon RC, Rothrock N, Hanrahan R, Bass M, Cella D. The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research. J Appl Meas 2010;11:304–14.
  • Rothrock NE, Hays RD, Spritzer K, Yount SE, Riley W, Cella D. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol 2010;63:1195–204.
  • Owens DK. In the eye of the beholder: assessment of health-related quality of life. Hepatology 1998;27:292–3.
  • da Rocha NS, Power MJ, Bushnell DM, Fleck MP. Is there a measurement overlap between depressive symptoms and quality of life? Compr Psychiatry 2009;50:549–55.
  • Trompenaars FJ, Masthoff ED, Van Heck GL, Hodiamont PP, De Vries J. Relationship between mood related disorders and quality of life in a population of Dutch adult psychiatric outpatients. Depress Anxiety 2006;23:353–63.
  • Moore M, Hofer S, McGee H, Ring L. Can the concept of depression and quality of life be integrated using a time perspective? Health Qual Life Outcomes 2005;3:1–10.
  • Berlim M, Fleck M. Quality of life and major depression. In: Ritsner MS, Awad AG, eds. Quality of life impairment in schizophrenia, mood, and anxiety disorders. Dordrecht, Netherlands: Springer, 2007.
  • Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression: treatment manual. New York: Guilford, 1979.
  • Aigner M, Forster-Streffleur S, Prause W, Freidl M, Weiss M, Bach M. What does the WHOQOL-BREF measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder. Soc Psychiatry Psychiatr Epidemiol 2006;41:81–6.
  • Ritsner M. The distress/protection vulnerability model of quality of life impairment syndrome. In: Ritsner MS, Awad AG, eds. Quality of life impairment in schizophrenia, mood, and anxiety disorders. Dordrecht, Netherlands: Springer, 2007.
  • Ritsner M, Modai I, Endicott J, Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000;61:880–9.
  • Church MC. The conceptual and operational definition of quality of life: a systematic review of the literature [master of science thesis (Texas A&M University, 2004)]. http://repository.tamu.edu/bitstream/handle/1969.1/2771/etd-tamu-2004B-HEED-Church.pdf?sequence = 1
  • World Health Organization Quality of Life Group. The World Health Organization quality of life (WHOQOL) assessment: position paper from the World Health Organization. Soc Sci Med 1995;10:1403–9.
  • World Health Organization. WHOQOL-BREF. 2004. http://www.who.int/substance_abuse/research_tools/en/english_who qol.pdf.
  • World Health Organization. The World Health Organization Quality of Life (WHOQOL)-BREF: introduction, administration, scoring and generic version of the assessment. http://www.who.int/mental_health/media/en/76.pdf
  • Corring DJ, Cook JV. Use of qualitative methods to explore the quality-of-life construct from a consumer perspective. Psychiatr Serv 2007;58:240–4.
  • Kaplan RM, Ganiats TG, Sieber WJ, Anderson JP. The Quality of Well-Being scale: critical similarities and differences with SF-36. Int J Qual Health Care 1998;10:509–20.
  • Mathews WC, May S. EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care. Health Qual Life Outcomes 2007;5:5.
  • Savoia E, Fantini MP, Pandolfi PP. Assessing the construct validity of the Italian version of the EQ-5D: preliminary results from a cross-sectional study in North Italy. Health Qual Life Outcomes 2006;4:47.
  • Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473–83.
  • McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS SF-36 Short-Form Health Survey (SF-36), III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40–66.
  • Rush AJ, First MB, Blacker D, eds. Handbook of psychiatric measures. 2nd ed. Washington, DC: American Psychiatric Publishing, 2008.
  • McKenna SP, Hunt SM. A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS. Health Policy 1992;22:321–30.
  • DeJonghe F, McKenna SP. Quality of Life in Depression Scale (QLDS): development, reliability, validity, responsiveness and application. Eur Psychiatry 1997;12:199–202.
  • Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321–6.
  • Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 2005;162:1171–8.
  • Skevington S, Wright A. Changes in the quality of life of the patients receiving antidepressant medication in primary care: validation of the WHOQOL-100. Br J Psychiatry 2001;178:261–7.
  • Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHO-QOL group. Qual Life Res 2004;13:299–310.
  • Daly EJ, Trivedi MH, Wisniewski SR, Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry 2010;22:43–55.
  • Ezquiaga E, García-López A, de Dios C, Leiva A, Bravo M, Montejo J. Clinical and psychosocial factors associated with the outcome of unipolar major depression: a one year prospective study. J Affect Disord 2004;79:63–70.
  • Bonicatto SC, Dew MA, Zaratiegui R, Lorenzo L, Pecina P. Adult outpatients with depression: worse quality of life than in other chronic medical diseases in Argentina. Soc Sci Med 2001;52:911–9.
  • Saarijärvi S, Salminen JK, Toikka T, Raitasalo R. Health-related quality of life among patients with major depression. Nord J Psychiatry 2002;56:261–4.
  • Mittal D, Fortney J, Pyne J, Edlund M, Wetherell J. Impact of comorbid anxiety disorders on health-related quality of life among patients with major depressive disorder. Psychiatr Serv 2006;57:1731–7.
  • Brieger P, Ehrt U, Bloeink R, Marneros A. Consequences of comorbid personality disorders in major depression. J Nerv Ment Dis 2002;190:304–9.
  • Abrams RC, Alexopoulos GS, Spielman LA, Klausner E, Kakuma T. Personality disorder symptoms predict declines in global functioning and quality of life in elderly depressed patients. Am J Geriatr Psychiatry 2001;9:67–71.
  • Saatcioglu O, Yapici A, Cakmak D. Quality of life, depression and anxiety in alcohol dependence. Drug Alcohol Rev 2008;27:83–90.
  • Holzapel N, Zugck C, Muller-Tasch T, Lowe B. Routine screening for depression and quality of life in outpatients with congestive heart failure. Psychosomatics 2007;48:112–6.
  • Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003;29:215–21.
  • Swenson JR, O'Connor CM, Barton D, Van Zyl L. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003;92:1271–6.
  • Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004;27:1066–70.
  • Cully J, Graham MS, Stanley M, Ferguson C. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2004;47: 312–9.
  • Adewuya AO, Afolabi MO, Ola BA, Relationship between depression and quality of life in persons with HIV infection in Nigeria. Int J Psychiatry Med 2008;38:43–51.
  • Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry 1996;153:1411–7.
  • Pyne JM, Patterson TL, Kaplan RM, Gillin JC, Koch WL, Grant I. Assessment of the quality of life of patients with major depression. Psychiatr Serv 1997;48:224–30.
  • Fleck MP, Simon G, Herrman H, Bushnell D, Martin M, Patrick D. Major depression and its correlates in primary care settings in six countries. Br J Psychiatry 2005;186:41–7.
  • Berlim MT, Mattevi BS, Fleck MP. Depression and quality of life among depressed Brazilian outpatients. Psychiatr Serv 2003;54:254.
  • Berlim MT, McGirr A, Fleck MP. Can sociodemographic and clinical variables predict the quality of life of outpatients with major depression? Psychiatry Res 2008;160:364–71.
  • Trivedi HM, Rush AJ, Wisniewski RS, Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. J Clin Psychiatry 2006;67:185–95.
  • Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 2004;26:13–7.
  • Shelton RC, Haman KL, Rapaport MH, A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. J Clin Psychiatry 2006;67:1674–81.
  • Reed C, Monz BU, Perahia DG, Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER. J Affect Disord 2009;113:296–302.
  • Angermeyer MC, Holzinger A, Matschinger H, Stenger-Wenzke K. Depression and quality of life: results of a follow-up study. Int J Soc Psychiatry 2002;48:189–99.
  • Acil AA, Dogan S, Dogan O. The effects of physical exercises to mental state and quality of life in patients with schizophrenia. J Psychiatr Ment Health Nurs 2008;15:808–15.
  • Larun L, Nordheim LV, Ekeland E, Hagen KB, Heian F. Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database Syst Rev 2006;3:CD004691.
  • Nyklícek I, Kuijpers KF. Effects of mindfulness-based stress reduction intervention on psychological well-being and quality of life: is increased mindfulness indeed the mechanism? Ann Behav Med 2008;35:331–40.
  • Hamre HJ, Witt CM, Glockmann A, Ziegler R, Willich SN, Kiene H. Rhythmical massage therapy in chronic disease: a 4-year prospective cohort study. J Altern Complement Med 2007;13:635–42.
  • Marziali E, McDonald L, Donahue P. The role of coping humor in the physical and mental health of older adults. Aging Ment Health 2008;12:713–8.
  • Wong DF. Cognitive and health-related outcomes of group cognitive behavioural treatment for people with depressive symptoms in Hong Kong: randomized wait-list control study. Aust N Z J Psychiatry 2008;42:702–11.
  • Van der Watt G, Laugharne J, Janca A. Complementary and alternative medicine in the treatment of anxiety and depression. Curr Opin Psychiatry 2008;21:37–42.
  • IsHak WW, Davis M, Jeffrey J, The role of dopaminergic agents in improving quality of life in major depressive disorder. Curr Psychiatry Rep 2009;11:503–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.